Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: At $0.042, the current capitalization of PTSC is less then $17 million.

You also have to remember that PTSC is only a 50% owner of the patents. Moore owns the other half. Who in their right mind would buy up this co?

No one.

Share
New Message
Please login to post a reply